Clinical Trial Update: Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) [NA]

View source ↗

Summary

This document reports the completion of a pilot study evaluating irreversible electroporation (IRE) for treating early-stage hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Angiodynamics, Inc. | Conditions: Carcinoma, Hepatocellular | NA | Status: COMPLETED